Home›Companies›Biotech & Pharma›Analytica Biosciences

Analytica Biosciences Corp.

Updated Oct 27, 2026·Latest SEC filing Sep 19, 2023·Suggest an edit

About Analytica Biosciences

Analytica Biosciences is a private company based in Naples, Florida, incorporated in 2023 in Delaware. It has reported $10,000 raised in one offering on Form D since September 2023. Its chief executive is Asuna Gilfoyle.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Sep 12, 2023Sep 13, 2023amended Sep 19, 2023$10,000of $1.0M target1$10,000EquityRule 506(b)Form D/A ↗1 earlier filing

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Analytica Biosciences's Form D filed Sep 19, 2023.

AG
Asuna Gilfoyle
CEO & Chief Scientist, director

Sources

  1. SECAnalytica Biosciences Corp. Form D, filed Sep 13, 2023
  2. SECAnalytica Biosciences Corp. filing history